The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GEM20110714: Final overall survival results of the phase III study of first-line gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma.
 
Shaodong Hong
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Yunpeng Yang
No Relationships to Disclose
 
Gengsheng Yu
No Relationships to Disclose
 
Jun Jia
No Relationships to Disclose
 
Jiewen Peng
No Relationships to Disclose
 
Qing Lin
No Relationships to Disclose
 
Xuping Xi
No Relationships to Disclose
 
Peijian Peng
No Relationships to Disclose
 
Dongping Chen
No Relationships to Disclose
 
Mingjun Xu
No Relationships to Disclose
 
Xiaojun Lu
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose